𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo association of CReMM/CHD9 with promoters in osteogenic cells

✍ Scribed by I. Shur; R. Socher; D. Benayahu


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
272 KB
Volume
207
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Molecular mechanisms that control cell differentiation involve with chromatin remodeling activities. We recently identified Chromatin Related Mesenchymal Modulator (CReMM), a CHD protein expressed by mesenchymal cells. In this study, we analyzed CReMM expression on RNA and protein levels during embryonic development in mouse skeletal tissues. CReMM appears transiently during mesenchymal cell differentiation, being detected first in osteoprogenitors and declining in mature cells. A novel aspect of the study elaborates on in vivo association of CReMM with promoters in cells obtained by laser capture micro‐dissection (LCM) technique from periosteum and endochondreal ossification regions. Using chromatin immunoprecipitation (ChIP), we proved that CReMM binds to skeletal tissue‐specific promoters: CBFA1, biglycan, osteocalcin (OC), collagen‐II, and myosin in a differential manner. The results imply that CReMM selectively interacts with analyzed promoters activated in the tissue at the appropriate time of development. The identification of CReMM and its tissue distribution and function provides an attractive clue for the study of transcriptional regulation of osteogenic cells' maturation. J. Cell. Physiol. 207: 374–378, 2006. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Molecular and cellular characterization
✍ I. Shur; R. Socher; M. Hameiri; A. Fried; D. Benayahu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

## Abstract We describe a novel human gene, named __SEL‐OB/SVEP1__, expressed by skeletal tissues in vivo and by cultured osteogenic cells. The mRNA expression was analyzed on frozen tissues retrieved by laser‐capture microscope dissection (LCM) and was detected in osteogenic tissues (periosteum an

Apomine™, an inhibitor of HMG-CoA-reduct
✍ Claire M. Edwards; Gabrielle Mueller; Anke J. Roelofs; Andrew Chantry; Mark Perr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 367 KB

## Abstract Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG‐CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis __in vitro__ and modulate myeloma di

Association of matrix metalloproteinase-
✍ Enping Xu; Xiaoping Xia; Bingjian Lü; Xiaoming Xing; Qiong Huang; Yu Ma; Wei Wan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract Matrix metalloproteinase‐2 (MMP‐2) and ‐9 (MMP‐9) play an important role in cancer initiation, invasion, and metastasis. The aim of this study was to investigate whether common genetic variants in these two key MMPs are associated with the development and progression of colorectal cance

Wnt11 and Wnt7a are up-regulated in asso
✍ Jacqueline Bond; David Sedmera; Jane Jourdan; Yuhua Zhang; Carol A. Eisenberg; L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

## Abstract The heart beat is coordinated by a precisely timed sequence of action potentials propagated through cells of the conduction system. Previously, we have shown that conduction cells in the chick embryo are derived from multipotent, cardiomyogenic progenitors present in the looped, tubular

Fas ligand expressed in colon cancer is
✍ Aileen Houston; Frank D. Waldron-Lynch; Michael W. Bennett; Desmond Roche; Geral 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 267 KB

## Abstract Expression of Fas ligand (FasL/CD95L) may help to maintain colon cancers in a state of immune privilege by inducing apoptosis of antitumor immune effector cells. Colon tumor‐derived cell lines appear to be relatively insensitive to apoptosis mediated by their own or exogenous FasL __in

Regulation of RANKL promoter activity is
✍ Xian Fan; Eileen M. Roy; Tamara C. Murphy; Mark S. Nanes; Sungtae Kim; J. Wesley 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

## Abstract Receptor activator of NFκ‐B ligand (RANKL) is essential for osteoclast formation, function, and survival. Although RANKL mRNA and protein levels are modulated by 1,25(OH)~2~D~3~ and other osteoactive factors, regulatory mechanisms remain unclear. In this study, we show that 2 kb or 2 kb